The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-benzyl-4-fluoro-N-((3'-(piperazin-1-ylmethyl)biphenyl-4-yl)methyl)benzenesulfonamide ID: ALA1090238
PubChem CID: 46886359
Max Phase: Preclinical
Molecular Formula: C31H32FN3O2S
Molecular Weight: 529.68
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=S(=O)(c1ccc(F)cc1)N(Cc1ccccc1)Cc1ccc(-c2cccc(CN3CCNCC3)c2)cc1
Standard InChI: InChI=1S/C31H32FN3O2S/c32-30-13-15-31(16-14-30)38(36,37)35(23-25-5-2-1-3-6-25)24-26-9-11-28(12-10-26)29-8-4-7-27(21-29)22-34-19-17-33-18-20-34/h1-16,21,33H,17-20,22-24H2
Standard InChI Key: LZBKXBZDNHTOOM-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 42 0 0 0 0 0 0 0 0999 V2000
-5.0833 -7.5966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0847 -8.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3696 -8.8360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6526 -8.4246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6559 -7.5926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.3716 -7.1858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9472 -7.1764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2296 -7.5871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5172 -7.1711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.5212 -6.3445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2436 -5.9357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9530 -6.3540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8089 -5.9268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0910 -6.3349 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6212 -5.9173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6157 -5.0915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3312 -4.6776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3260 -3.8526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6075 -3.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1071 -3.8659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0984 -4.6895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0874 -7.1622 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.8441 -7.6228 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0904 -7.9802 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6254 -7.5707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6254 -8.3934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3375 -8.8018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0487 -8.3885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0432 -7.5627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3306 -7.1581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7656 -8.7980 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-5.7981 -7.1832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7974 -6.3574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.0808 -5.9485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0781 -5.1264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7911 -4.7091 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.5084 -5.1201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5127 -5.9484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4 5 1 0
18 19 2 0
9 10 2 0
19 20 1 0
2 3 1 0
20 21 2 0
21 16 1 0
10 11 1 0
14 22 1 0
5 6 2 0
22 23 2 0
11 12 2 0
22 24 2 0
12 7 1 0
22 25 1 0
5 7 1 0
25 26 2 0
6 1 1 0
26 27 1 0
10 13 1 0
27 28 2 0
1 2 2 0
28 29 1 0
13 14 1 0
29 30 2 0
30 25 1 0
3 4 2 0
28 31 1 0
14 15 1 0
1 32 1 0
7 8 2 0
32 33 1 0
33 34 1 0
15 16 1 0
16 17 2 0
8 9 1 0
17 18 1 0
33 38 1 0
34 35 1 0
35 36 1 0
36 37 1 0
37 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 529.68Molecular Weight (Monoisotopic): 529.2199AlogP: 5.29#Rotatable Bonds: 9Polar Surface Area: 52.65Molecular Species: BASEHBA: 4HBD: 1#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 9.26CX LogP: 5.67CX LogD: 3.82Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.32Np Likeness Score: -1.40
References 1. Zuercher WJ, Buckholz RG, Campobasso N, Collins JL, Galardi CM, Gampe RT, Hyatt SM, Merrihew SL, Moore JT, Oplinger JA, Reid PR, Spearing PK, Stanley TB, Stewart EL, Willson TM.. (2010) Discovery of tertiary sulfonamides as potent liver X receptor antagonists., 53 (8): [PMID:20345102 ] [10.1021/jm901797p ]